Pembrolizumab: a new PD-1 inhibitor as first-line therapy for non-small cell lung cancer
ZHANG Jing-ru
ZHAO Li-bo
GU Jian
Machine-generated Keywords:
Publication Date:2018-01-01
Online Publishing Date:2026-08-14(First online date of this platform, not the publication date of the document)
Pages:4( 969-972 )
